Spotlight: Supporting cancer patients in community pharmacy

+Print Archive
Spotlight

Spotlight: Supporting cancer patients in community pharmacy

Hee Seung Lee

HeeSeung Lee

cancer, teenager, adolescent

Every day, 63 New Zealanders will hear a sentence no one wants to hear: “You have cancer”. All up, there are more than 22,000 new cancer cases each year. While cancer treatment is traditionally handled by secondary care, there is a support role for primary care, especially pharmacy. Auckland pharmacy owner Hee Seung Lee, speaks to reporter Jonathan Chilton-Towle about what pharmacy staff can do to support patients receiving cancer treatment and their families and raise awareness of available early screening programmes

Common cancer issues, Having cancer is a horrible experience and cancer ­treatment can result in many nasty side effects. Be aware cancer patients may need assistance with
References
  1. Migraine Research Foundation. Migraine Facts. https://bit.ly/39vl218

  2. Fookes C (Tech Ed). Migraine. In Healthcare Handbook 2019–2020. Auckland, NZ: The Health Media Ltd; 2019.

  3. Neurological Foundation. Migraine. https://bit.ly/2xy7BjM

  4. Mayo Clinic. Migraine. https://mayocl.in/3dE2dMz

  5. Web MD. Food Triggers for Migraines. January 2019. https://wb.md/2JpwnoU

  6. The Migraine Trust. Common triggers. https://bit.ly/3dBflC5

  7. New Zealand Formulary. 4.7.4.1: Treatment of acute migraine. March 2020. https://nzf.org.nz/nzf_2557

  8. Derry S, Moore RA. Paracetamol (acetaminophen) with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013;(4):CD008040.

  9. Kirthi V, Derry S, Moore RA. Aspirin with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013;(4):CD008041.

  10. Rabbie R, Derry S, Moore R. Ibuprofen with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013;(4):CD008039.

  11. Derry S, Rabbie R, Moore R. Diclofenac with or without an antiemetic for acute migraine headaches in adults. Cochrane Database Syst Rev 2013;(4):CD008783.

  12. Derry CJ, Derry S, Moore RA. Sumatriptan (oral route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev 2012;2:CD008615.

  13. Derry CJ, Derry S, Moore RA. Sumatriptan (subcutaneous route of administration) for acute migraine attacks in adults. Cochrane Database Syst Rev 2012;2:CD009665.

  14. Láinez MJ. Rizatriptan in the treatment of migraine. Neuropsychiatr Dis Treat 2006;2(3):247–59.

  15. Medsafe. Consent to distribute Cafergot tablets (ergotamine tartrate 1 mg + caffeine 100 mg) will be prohibited under Section 36 of the Medicines Act 1981 on 1 May 2020. November 2019. https://bit.ly/3dD0jvz

  16. The Migraine Trust. CGRP pathway monoclonal antibodies. https://bit.ly/3aw9agW

  17. Medsafe. Medsafe Product Detail: Aimovig Solution for injection, 70 mg/mL (Prescription). May 2019. https://bit.ly/2QS09ac

  18. The Migraine Trust. Medication-overuse headache. https://bit.ly/2UsTbL2

  19. Facchinetti F, Sances G, Borella P, et al. Magnesium prophylaxis of menstrual migraine: effects on intracellular magnesium. Headache 1991;31(5):298–301.

  20. Peikert A, Wilimzig C, Köhne-Volland, R. Prophylaxis of migraine with oral magnesium: Results from a prospective, multicenter, placebo-controlled and double-blind randomized study. Cephalalgia 1996;16(4):257–63.

  21. Pfaffenrath V, Wessely P, Meyer C, et al. Magnesium in the prophylaxis of migraine—a double-blind placebo-controlled study. Cephalalgia 1996;16(6):436–40.

  22. Murphy JJ, Heptinstall S, Mitchell JRA. Randomised double-blind placebo-controlled trial of feverfew in migraine prevention. Lancet 1988;2(8604):189–92.

  23. Johnson ES, Kadam NP, Hylands DM, et al. Efficacy of feverfew as prophylactic treatment of migraine. Br Med J (Clin Res Ed) 1985;291(6495):569–73.

  24. Rozen TD, Oshinsky ML, Gebeline CA, et al. Open label trial of coenzyme Q10 as a migraine preventive. Cephalalgia 2002;22(2):137–41.

  25. Sándor PS, Di Clemente L, Coppola G, et al. Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial. Neurology 2005;64(4):713–15.

  26. Schoenen J, Jacquy J, Lenaerts M. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial. Neurology 1998;50(2):466–70.